Crescita Therapeutics (CTX) Stock Price, News & Analysis

Company Overview

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.

Key Stats

• Today's Range: C$0.52 to C$0.52
• 50-Day Range: C$0.51 to C$0.60
• 52-Week Range: C$0.41 to C$0.69
• Volume: 10,111 shs
• Average Volume: 14,608 shs
• Market Capitalization: C$9.57 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CTX Stock Analysis - Frequently Asked Questions

How have CTX shares performed this year?

Crescita Therapeutics' stock was trading at C$0.58 on January 1st, 2025. Since then, CTX shares have decreased by 10.3% and is now trading at C$0.52.
View the best growth stocks for 2025 here.

How do I buy shares of Crescita Therapeutics?

Shares of CTX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of Crescita Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Crescita Therapeutics investors own include Baytex Energy (BTE), Argonaut Gold (AR), Birchcliff Energy (BIR), CBTX (CBTX), Crescent Point Energy (CPG), Enbridge (ENB) and IMV (IMV).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: TSE:CTX
• CIK: N/A
• Web: www.crescitatherapeutics.com
• Phone: +1-905-6734295
• Fax: N/A
• Employees: 62
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): C($0.15)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: C$-2,614,925.18
• Net Margins: -15.73%
• Pretax Margin: N/A
• Return on Equity: -15.60%
• Return on Assets: -8.26%

Debt

• Debt-to-Equity Ratio: 5.77
• Current Ratio: 2.70
• Quick Ratio: 2.29

Sales & Book Value

• Annual Sales: C$16.62 million
• Price / Sales: 0.60
• Cash Flow: C$0.45 per share
• Price / Cash Flow: 1.20
• Book Value: C$0.83 per share
• Price / Book: 0.65

Miscellaneous

• Outstanding Shares: 18,406,184
• Free Float: N/A
• Market Cap: C$9.94 million
• Optionable: Not Optionable
• Beta: 1.69